Table 3.

Association between chicken ovalbumin upstream promoter transcription factor (COUP‐TF) II immunoreactivity and clinicopathological parameters in 119 breast carcinomas

Variable	Patient number	COUP‐TFII labeling index (%)	P‐value	P‐value adjusted by Bonferroni
Menopausal status
pre‐	51	24.9 ± 3.4
post‐	68	27.5 ± 3.3	0.7616
Stage
I	32	21.9 ± 4.5
II	58	22.6 ± 3.0	0.9071 (I vs II)
III	13	26.0 ± 7.6	0.6247 (I vs III)
IV	16	44.8 ± 7.4	0.0037 (I vs IV)	0.0222
Tumor size (cm)
≥2.5	65	26.6 ± 3.1
<2.5	54	24.8 ± 3.6	0.582
Lymph node status
Positive	46	34.1 ± 4.3
Negative	73	20.5 ± 2.6	0.0369
Histological grade
1 (well)	34	15.3 ± 3.3
2 (moderate)	44	28.6 ± 4.0	0.0231 (1 vs 2)	0.0693
3 (poor)	41	31.3 ± 4.4	0.0074 (1 vs 3)	0.0222
Estrogen receptor α status
Positive	83	29.8 ± 3.0
Negative	36	16.5 ± 3.6	0.0050
Progesterone receptor status
Positive	78	26.7 ± 2.9
Negative	41	24.0 ± 4.2	0.2964
Ki‐67 status
Positive	72	28.8 ± 3.1
Negative	47	21.1 ± 3.6	0.1157
HER2 status
Positive	27	28.2 ± 5.5
Negative	92	25.4 ± 2.6	0.8364

Data are presented as means ± SEM. All other values represent the number of cases. P‐values less than 0.05 were considered significant, and are shown in bold. HER, XXX.